Checkpoint receptors in circulating γδ T cells can discern the outcome of cancer immunotherapy
Elisa Catafal Tardos, Lola Dachicourt, María Virginia Baglioni, Marcelo Gregorio Filho Fares da Silva, Davide Secci, Marco Donia, Anders Handrup Kverneland, Inge Marie Svane, Vasileios Bekiaris
This study examines how checkpoint receptors in circulating γδ T cells correlate with cancer immunotherapy outcomes, identifying potential prognostic markers and therapeutic targets.
EMBO Molecular Medicine · Nov 27, 2025Peer-reviewedImmunology